| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |